Quantamental Technologies LLC Xencor Inc Transaction History

Quantamental Technologies LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$32.75 - $41.43 $185,332 - $234,452	-5,659 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$33.73 - $46.27 $127,937 - $175,502	3,793 Added 203.27%	5,659 $191,000
Q2 2019 Aug 12, 2019	BUY	$29.6 - $40.93 $55,233 - $76,375	1,866 New	1,866 $76,000

204

63.1M

3.9K

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.26B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantamental Technologies LLC with notifications on news.